» Articles » PMID: 11964822

Enteropathogenic and Enterohaemorrhagic Escherichia Coli and Diarrhoea

Overview
Date 2002 Apr 20
PMID 11964822
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Enteropathogenic and enterohaemorrhagic Escherichia coli are important causes of bacterial gastroenteritis with the potential for progression to more serious syndromes, especially in the case of enterohaemorrhagic E. coli. Consequently, recent developments in molecular epidemiology and treatment regimens have focused on enterohaemorrhagic E. coli, while the similar initial pathogenic mechanisms of both enterohaemorrhagic and enteropathogenic E. coli continue to be investigated in detail. The carriage of most E. coli virulence determinants on pathogenicity islands, plasmids or phages allows the rapid evolution of these pathotypes, which need to be monitored closely.

Citing Articles

Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7.

Tree J, Wang D, McInally C, Mahajan A, Layton A, Houghton I Infect Immun. 2009; 77(10):4209-20.

PMID: 19635828 PMC: 2747932. DOI: 10.1128/IAI.00562-09.


Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep.

Stevens M, Roe A, Vlisidou I, van Diemen P, La Ragione R, Best A Infect Immun. 2004; 72(9):5402-11.

PMID: 15322038 PMC: 517426. DOI: 10.1128/IAI.72.9.5402-5411.2004.


Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.

Viswanathan V, Koutsouris A, Lukic S, Pilkinton M, Simonovic I, Simonovic M Infect Immun. 2004; 72(6):3218-27.

PMID: 15155623 PMC: 415647. DOI: 10.1128/IAI.72.6.3218-3227.2004.


Efa1 influences colonization of the bovine intestine by shiga toxin-producing Escherichia coli serotypes O5 and O111.

Stevens M, van Diemen P, Frankel G, Phillips A, Wallis T Infect Immun. 2002; 70(9):5158-66.

PMID: 12183566 PMC: 128238. DOI: 10.1128/IAI.70.9.5158-5166.2002.


Inhibition of attaching and effacing lesion formation following enteropathogenic Escherichia coli and Shiga toxin-producing E. coli infection.

Johnson-Henry K, Wallace J, Basappa N, Soni R, Wu G, Sherman P Infect Immun. 2001; 69(11):7152-8.

PMID: 11598092 PMC: 100109. DOI: 10.1128/IAI.69.11.7152-7158.2001.